Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolution.

Heart (British Cardiac Society)

Volumn 94, Issue 3, 2008, Pages

  Toma, M ^a   Fu, Y ^a   Wagner, G ^a   Goodman, S G ^a   Granger, C ^a   Wallentin, L ^a   Van de Werf, F ^a   Armstrong, P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; THROMBOLYTIC THERAPY;

MLCS; MLOWN;

EID: 42949109289     PISSN: None     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.118166     Document Type: Article

References (0)